» Articles » PMID: 2164470

Molecular Cloning and Expression of Glycogen Synthase Kinase-3/factor A

Overview
Journal EMBO J
Date 1990 Aug 1
PMID 2164470
Citations 478
Authors
Affiliations
Soon will be listed here.
Abstract

Glycogen synthase kinase-3 (GSK-3) is a protein-serine kinase implicated in the hormonal control of several regulatory proteins including glycogen synthase and the transcription factor c-jun. Two classes of rat brain cDNA for this enzyme have been isolated termed GSK-3 alpha and GSK-3 beta. The alpha-type encodes a 51 kd polypeptide, the sequence of which includes all of the tryptic peptides determined by protein sequence analysis of purified skeletal muscle GSK-3. The novel beta-type cDNA has the potential to encode a 47 kd protein with 85% amino acid identity to GSK-3 alpha. The two types of cDNA are the products of distinct genes as determined by genomic organization and nucleic acid sequence analysis. Both alpha and beta clones exhibit kinase activity when expressed in COS-1 cells and type-specific antibodies to GSK-3 alpha and beta detect proteins of 51 and 47 kd, respectively, in a variety of rat tissue extracts, with highest levels of both in brain. Partial purification of GSK-3 activity from bovine brain results in the isolation of active alpha and beta proteins. The physiological importance of these two proteins in cellular signal transduction is discussed.

Citing Articles

RhoA/ROCK/GSK3β Signaling: A Keystone in Understanding Alzheimer's Disease.

Medd M, Yon J, Dong H Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996845 PMC: 11854763. DOI: 10.3390/cimb47020124.


Identification of a novel pyrrolo[2,3-]pyridine compound as a potent glycogen synthase kinase 3β inhibitor for treating Alzheimer's disease.

Xun Q, Zhang J, Feng L, Ma Y, Li Y, Shi X J Enzyme Inhib Med Chem. 2025; 40(1):2466846.

PMID: 39976249 PMC: 11843656. DOI: 10.1080/14756366.2025.2466846.


Docking and structure activity relationship studies of potent and selective thiazolidinethione GSK-3 inhibitors.

Boesger H, Williams K, Abdullai S, Hubble B, Noori M, Orac C Bioorg Med Chem Lett. 2024; 117:130074.

PMID: 39694339 PMC: 11808539. DOI: 10.1016/j.bmcl.2024.130074.


Radiosynthesis and evaluation of a novel F-labeled tracer for PET imaging of glycogen synthase kinase 3.

Xiao Z, Li Y, Haider A, Pfister S, Rong J, Chen J Am J Nucl Med Mol Imaging. 2024; 14(5):327-336.

PMID: 39583910 PMC: 11578811. DOI: 10.62347/OBZS8887.


Exploring bacterial metabolites in microbe-human host dialogue and their therapeutic potential in Alzheimer's diseases.

Singh S, Bharali P, Nagamani S Mol Divers. 2024; .

PMID: 39499489 DOI: 10.1007/s11030-024-11028-y.


References
1.
Tung H, Reed L . Purification and characterization of protein phosphatase 1I activating kinase from bovine brain cytosolic and particulate fractions. J Biol Chem. 1989; 264(5):2985-90. View

2.
Smith D, Johnson K . Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene. 1988; 67(1):31-40. DOI: 10.1016/0378-1119(88)90005-4. View

3.
Mitchell P, Tjian R . Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science. 1989; 245(4916):371-8. DOI: 10.1126/science.2667136. View

4.
Cohen P . The structure and regulation of protein phosphatases. Annu Rev Biochem. 1989; 58:453-508. DOI: 10.1146/annurev.bi.58.070189.002321. View

5.
Parker P, Kour G, Marais R, Mitchell F, Pears C, Schaap D . Protein kinase C--a family affair. Mol Cell Endocrinol. 1989; 65(1-2):1-11. DOI: 10.1016/0303-7207(89)90159-7. View